Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF for Inherited Bone Marrow Failure Syndromes
NCT00004787Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Dec 1994
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of filgrastim in Fanconi anemia (FA), dyskeratosis congenita (DC), Shwachman-Diamond syndrome (SDS), Amegakaryocytic Thrombocytopenia (CAMT), sponsored by National Center for Research Resources. Started Dec 1994; status: completed.
02
Drugs
filgrastim
03
Conditions
Fanconi anemia (FA)dyskeratosis congenita (DC)Shwachman-Diamond syndrome (SDS)Amegakaryocytic Thrombocytopenia (CAMT)
Beyond the preview
Go deeper on NCT00004787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004787.